S159
ESTRO 36 2017
_______________________________________________________________________________________________
Symposium: Registration and fusion techniques
SP-0310 Rigid registration techniques for different
imaging modalities
N. Nesvacil
1
1
Medical University of Vienna, Department of
Radiotherapy- CCC- Christian Doppler Laboratory for
Medical Radation Research for Radiation Oncology,
Vienna, Austria
Image registration has become an important part of
treatment planning and execution in 3D image guided
external beam radiotherapy (EBRT) and brachytherapy
(BT) during the last decades. In principle, the same
algorithms for rigid or non-rigid image registration can be
applied to either type of radiotherapy. However, for their
application in brachytherapy the presence of the
brachytherapy delivery device, i.e. the applicator, plays
an essential role. This presentation will provide an
overview of rigid registration techniques in
brachytherapy, compared to external beam radiotherapy.
In gynaecological brachytherapy, where the applicator
and CTV might move in relation to the bony anatomy
during the course of a (multi-fractionated) treatment,
applicator-based rigid registration can be used to combine
images for treatment planning acquired with the same or
different modalities at different time points. One of the
most useful applications of this technique is to transfer
target contours defined on a reference image, e.g. an MRI
at the time of the first BT, to subsequent CT image
volumes for planning of further BT fractions, if MRI is not
always available for dose plan adaptation to the anatomy
of the day. Requirements and pitfalls for clinical
applications of this technique will be discussed. In order
to analyse interfraction variations for target and organs at
risk (OARs) based on image volumes acquired at different
time points, rigid image registration can provide a good
estimate of the dosimetric impact of anatomical changes
between applicator, CTV and OARs. Clinical examples will
be discussed for different treatment sites. Limitations of
the technique will be summarized and special focus will
be given to prostate and gynaecological BT treatment
planning.
Multi-modal rigid image registration for brachytherapy is
also used to improve target delineation and dose plan
optimization for a single fraction. MRI acquired before
brachytherapy can be combined with CT images for
treatment planning of prostate cancer, in order to
visualize and delineate intraprostatic lesions as boost
target volumes in HDR or LDR brachytherapy.
In the setting of gynaecological cancer brachytherapy
where only CT is available for visualization of the
applicator and surrounding organs after implantation,
rigid registration of ultrasound images obtained with
applicator in situ could be used in the future for dual
modality dose planning of a single fraction. Challenges and
solutions for the registration of ultrasound and CT images,
such as determining the applicator position in the
ultrasound image volume, will be explored to conclude
this presentation.
SP-0311 Deformable registration for dose summation
K. Tanderup
1
1
Aarhus University Hospital, Department of Oncology,
Aarhus C, Denmark
Dose summation across brachytherapy fractions and
accumulation with external beam radiotherapy (EBRT)
dose is essential for assessment of total dose to both
targets and organs at risk in treatments with fractionated
brachytherapy and in combinations with EBRT.
Brachytherapy
dose
distributions
are
highly
heterogeneous, and the EBRT dose distribution may also
include significant dose gradients in the vicinity of the
brachytherapy high dose region, e.g. in case of lymph node
boosts. Organ motion between fractions as well as change
in anatomy between brachytherapy and EBRT constitute
specific challenges for dose summation. Deformable
image registration (DIR) aims to match each tissue voxel
irradiated by each fraction of external-beam radiation
with the corresponding voxel irradiated by each fraction
of brachytherapy. However, DIR is related with specific
uncertainties and does not necessarily provide added
value for dose accumulation. The alternative of
accumulating dose through DIR is to perform direct
addition of DVH parameters as recommended in the ICRU
report 89. Direct addition assumes inherently that hot
spots and cold spots remain in the same spatial region
across suceeding fractions and is therefore also related
with uncertainties or even not appropriate for certain
scenarios. DIR can be carried out with deformation models
based on image intensity, biomechanical models, or
combinations of these. Biomechanical models take into
account organ shapes and potentially biomechanical
properties of organs or organ walls/surfaces, such as
elasticity. Biomechanical models based on contours need
to have these defined in both source and target images,
and the correspondence of contours becomes part of the
objective function which drives the optimisation. DIR
models based entirely on image intensity do not take into
account contours, and the objective function is based on
correspondence in image intensity. The major questions
with regard to DIR and dose accumulation in
brachytherapy are: 1) Is it problematic to accumulate dose
without DIR? I.e. what is the accuracy and limitations of
dose accumulation with DVH addition? 2) Can DIR solve the
problem? I.e. what is the accuracy of DIR-based dose
accumulation? For summation of EBRT and brachytherapy,
direct DVH addition is accurate if the EBRT dose
distribution is homogenous in the region where the BT
boost is going to be delivered. In case of a homogeneous
EBRT dose, the EBRT dose contribution to the primary
target D
90%
and D
98%
as well as D
2cm3
for organs at risk will
be equal to the prescribed EBRT dose. Dose distributions
from four-field -box techniques are normally
homogeneous . Furthermore, it is also possible to control
the homogeneity of IMRT and VMAT in the region the the
BT boost through dose optimisation, e.g. by introducing
help structures in the region of the primary target/GTV
with specific constraints on homogeneity. However, in the
case of lymph node boosts which are in close relation to
the primary target and the BT boosted region, direct
addition of EBRT and BT DVH parameters may not reflect
the true accumulated dose. DIR has not been investigated
for this purpose, but may provide an added value. For
summation of dose from succeeding BT fractions, there
are indications that DVH addition has an accuracy better
than 5% for organs such as bladder and rectum, as hotspots
are quite stable across brachytherapy fractions. For target
structures, there have not been any systematic
evaluations, but often cold spots are located in the same
region of the target, and DVH addition is assumed to work
well. For highly mobile organs such as sigmoid colon or
bowel loops, it is well know that hotspots may end up in
very different parts of the loops and DVH addition is
expected to significantly overestimate the hotspot dose.
DIR algorithms which are based on contours and
biomechanical models have been demonstrated to work
well for bladderand improves dose assessment although
the improvement with DIR as compared to direct DVH
addition is normally less than 5%. However, some DIR
algorithms based on image intensities can be related with
significant uncertainties and may provide dose
assessments which are less accurate than with DVH
addition, and DIR should therefore be used with great
caution. Sigmoid and bowel are highly deformable organs
and represent a significant challenge for DIR. There are